New World Pharmaceuticals, LLC
↗Charleston, South Carolina, United States
Founded in 2007, New World Pharmaceuticals is a privately held specialty pharmaceutical company headquartered in Charleston, South Carolina. The company is engaged in the research and development of innovative drug delivery systems designed to remove or mitigate constraints to taking medications and supplements. The company's core competency lies in developing proprietary controlled-release technologies for both oral and intradermal delivery routes. New World Pharmaceuticals focuses specifically on oral and intradermal controlled release technologies, leveraging patented temperature and pH responsive micro-gel technology that increases and sustains the bioavailability of drugs in BCS Class I, II, and III categories. The company operates with a leadership team possessing extensive senior management experience in both pharmaceutical and consumer goods industries.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharma - Drug Delivery Systems
SIZE & FINANCIALS
Employees:51-200
Founded:2007
Ownership:private
Status:operating
FUNDING
Stage:Post-Series (Growth)
Total Raised:$150K
Investors:SC Launch (South Carolina Research Authority venture capital program)
PIPELINE
Stage:Commercial (XRCEL launched)
Lead Drug Stage:XRCEL - Commercial/Consumer Product
Modalities:Small molecule, Temperature and pH responsive micro-gel systems, Intradermal delivery, Oral controlled release
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:New World Consumer Products, LLC (markets XRCEL brand)
Key Partnerships:South Carolina educational institutions (research collaboration), Quality Bicycle Products (XRCEL distribution - 2018), TricorBraun (packaging partner)
COMPETITION
Position:Niche Player
Competitors:Nanopass Technologies (intradermal delivery systems), LTS Lohmann Therapie-Systeme AG (transdermal and drug delivery systems), Abbott Laboratories (drug delivery devices), Medtronic plc (drug delivery systems), Novo Nordisk (drug delivery systems), Becton Dickinson (drug delivery devices), BIOCORP (drug delivery systems), Satio (intradermal drug delivery systems)
LEADERSHIP
Key Executives:
Fred Sexton - President & Founder, CEO
Scientific Founders:Fred Sexton
LINKS
Website:newworldpharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of New World Pharmaceuticals, LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with New World Pharmaceuticals, LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.